ÍøºìºÚÁÏ

Skip to main content

Larisa H Cavallari, PharmD, BCPS, BCPS, FCCP

Pharmacist

Photo of Larisa H Cavallari

Research at a glance

Top areas of exploration

  • Genotype , 81 publications
  • Pharmacogenetics , 65 publications
  • Warfarin , 57 publications
  • Anticoagulants , 49 publications

Research activity

230 publications

7,021 citations

Why is this important?

Active clinical trials

The Personlaized Medicine Program: Genotyping in Family Medicine Clinics

This study will examine the effect of having genotype information on pain management and pain control for patients treated in family medicine clinics. This study will also examine physician-perceived usefulness of genotype information. Patients will…

Investigator
Larisa H Cavallari
Status
Accepting Candidates
Ages
18 Years - 80 Years
Sexes
All

My publications

230 publications

2024

Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.

JACC. Basic to translational science

•

2024

CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.

Circulation

•

2024

CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention

Journal of the American Heart Association

2024

Decoding pharmacogenomic test interpretation and application to patient care

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY

•

2024

DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.

The Journal of molecular diagnostics : JMD

•